Abbott Diabetes

• The Case for Evaluating Continuous Glucose Monitoring as a Diagnostic Tool for Diabetes

  Fees or honoraria, 8 Oct 2026

• Association of GLP-1 receptor agonists, SGLT 2 inhibitors, DPP-4 inhibitors, and sulfonylureas with incident cancer in type 2 diabetes

  Consulting or advice, 17 Aug 2026

• Prediction of Incident Atrial Fibrillation and Association With Outcomes Using Routine Electronic Health Records in a Western Pacific Population

  Grants or research support, 6 Aug 2026

Sources: pubmed.ncbi.nlm.nih.gov

• Major Adverse Limb Events with Tirzepatide vs. Injectable Semaglutide in Adults with Type 2 Diabetes and Peripheral Artery Disease

  ADA Scientific Sessions 2026 abstract, 8 Jun 2026

• Relationship between BMI and Glucose Metrics in CGM Users in App-Enabled Weight Loss Program

  ADA Scientific Sessions 2026 abstract, 6 Jun 2026

• A Circulating microRNA Signature for Familial Risk of Type 2 Diabetes and Renal Failure

  ADA Scientific Sessions 2026 abstract, 6 Jun 2026

• Multimorbidity Phenotypes in Diabetes and Their Association with 10-Year Dementia Risk: A Latent Class Analysis in the UK Biobank

  ADA Scientific Sessions 2026 abstract, 6 Jun 2026

• Beyond Insulin Alone: One-Year CGM Outcomes of Adjunctive Incretin-Based and SGLT2 Inhibitors Therapy in Type 1 Diabetes Using Open-Source Automated Insulin Delivery Systems

  ADA Scientific Sessions 2026 abstract, 6 Jun 2026

• Vascular Age Gap Based on Carotid Intima-Media Thickness as a Marker of Early Vascular Aging in Adults with Type 1 Diabetes and Its Association with Diabetic Complications

  ADA Scientific Sessions 2026 abstract, 6 Jun 2026

• Multimorbidity Phenotypes in Diabetes and Their Association with All-Cause Mortality: A Latent Class Analysis in the UK Biobank

  ADA Scientific Sessions 2026 abstract, 5 Jun 2026

• Early Insulin Resistance Is a Stronger Predictor of Early than Late Gestational Diabetes

  ADA Scientific Sessions 2026 abstract, 5 Jun 2026

• Does the Inclusion of Lipoprotein(a) Levels Alter Cardiovascular Risk Assessment in Adults with Type 1 Diabetes Assessed Using the Steno T1 Risk Engine? Secondary Data Analysis from the InLipoDiab1 Cohort

  ADA Scientific Sessions 2026 abstract, 5 Jun 2026